By Iain Gilbert
Date: Thursday 28 Aug 2025
(Sharecast News) - Biotherapeutics firm Puretech Health said on Thursday that it had made "meaningful progress" across its portfolio in the first half of 2025, with contract revenues soaring throughout the period.
By Josh White
Date: Tuesday 12 Aug 2025
(Sharecast News) - PureTech Health announced the launch of Celea Therapeutics on Tuesday, a new company focused on developing treatments for serious respiratory diseases, led by former Teva North America chief executive Sven Dethlefs.
By Michele Maatouk
Date: Wednesday 16 Jul 2025
(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health said on Wednesday that chief executive officer Bharatt Chowrira has stepped down with immediate effect.
Currency | UK Pounds |
Share Price | 116.00p |
Closing Price Change | 1.00p |
% Change | 0.00 % |
52 Week High | 173.60p |
52 Week Low | 103.00p |
Volume | 0 |
Shares Issued | 241.68m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
15:48 | 293 @ 117.40p |
15:48 | 768 @ 117.20p |
15:48 | 1,006 @ 117.20p |
15:48 | 821 @ 117.20p |
15:48 | 876 @ 117.20p |
You are here: research